Bradykinin B2 Receptor Antagonists [MoA] - N0000182964

Pharmacologic Class Information

Pharmacologic Code N0000182964
Pharmacologic Name Bradykinin B2 Receptor Antagonists
Pharmacologic Uses
  • bradykinin B2 receptor antagonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Bradykinin B2 Receptor Antagonists

The following table contains 9 products whose active ingredient are classified under the same pharmacologic class Bradykinin B2 Receptor Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0093-3066Icatibant Non-Proprietary Name: IcatibantInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
24201-207Icatibant Non-Proprietary Name: IcatibantInjection, SolutionSubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
54092-702Firazyr Non-Proprietary Name: Icatibant AcetateInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
60505-6214Icatibant Non-Proprietary Name: Icatibant AcetateInjection, SolutionSubcutaneousApotex Corp.ACTIVE
63323-574Icatibant Non-Proprietary Name: IcatibantInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
68462-828Icatibant Non-Proprietary Name: Icatibant AcetateInjection, SolutionSubcutaneousGlenmark Pharmaceuticals Inc., UsaACTIVE
69097-664Icatibant Non-Proprietary Name: IcatibantInjectionSubcutaneousCipla Usa Inc.ACTIVE
70709-013Sajazir Non-Proprietary Name: IcatibantInjectionSubcutaneousCycle Pharmaceuticals Ltd-ukACTIVE
71225-114Icatibant Non-Proprietary Name: IcatibantInjectionSubcutaneousSlayback Pharma LlcACTIVE